These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22104972)

  • 1. Discovery of novel selective inhibitors of Staphylococcus aureus β-ketoacyl acyl carrier protein synthase III.
    Lee JY; Jeong KW; Shin S; Lee JU; Kim Y
    Eur J Med Chem; 2012 Jan; 47(1):261-9. PubMed ID: 22104972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel E. coli beta-ketoacyl-acyl carrier protein synthase III inhibitors as targeted antibiotics.
    Lee JY; Jeong KW; Lee JU; Kang DI; Kim Y
    Bioorg Med Chem; 2009 Feb; 17(4):1506-13. PubMed ID: 19185501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial natural products as beta-ketoacyl-acyl carrier protein synthase III inhibitors.
    Lee JY; Jeong KW; Shin S; Lee JU; Kim Y
    Bioorg Med Chem; 2009 Aug; 17(15):5408-13. PubMed ID: 19595597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III (FabH) as potential antibacterial agents.
    Shi L; Fang RQ; Zhu ZW; Yang Y; Cheng K; Zhong WQ; Zhu HL
    Eur J Med Chem; 2010 Sep; 45(9):4358-64. PubMed ID: 20557983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure and substrate specificity of the beta-ketoacyl-acyl carrier protein synthase III (FabH) from Staphylococcus aureus.
    Qiu X; Choudhry AE; Janson CA; Grooms M; Daines RA; Lonsdale JT; Khandekar SS
    Protein Sci; 2005 Aug; 14(8):2087-94. PubMed ID: 15987898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of vinylogous carbamates as a novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
    Li HQ; Luo Y; Zhu HL
    Bioorg Med Chem; 2011 Aug; 19(15):4454-9. PubMed ID: 21742506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platensimycin is a selective FabF inhibitor with potent antibiotic properties.
    Wang J; Soisson SM; Young K; Shoop W; Kodali S; Galgoci A; Painter R; Parthasarathy G; Tang YS; Cummings R; Ha S; Dorso K; Motyl M; Jayasuriya H; Ondeyka J; Herath K; Zhang C; Hernandez L; Allocco J; Basilio A; Tormo JR; Genilloud O; Vicente F; Pelaez F; Colwell L; Lee SH; Michael B; Felcetto T; Gill C; Silver LL; Hermes JD; Bartizal K; Barrett J; Schmatz D; Becker JW; Cully D; Singh SB
    Nature; 2006 May; 441(7091):358-61. PubMed ID: 16710421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and antibacterial activity studies of thiazole derivatives as potent ecKAS III inhibitors.
    Cheng K; Xue JY; Zhu HL
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4235-8. PubMed ID: 23731945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of C(7) modified chrysin derivatives designing to inhibit beta-ketoacyl-acyl carrier protein synthase III (FabH) as antibiotics.
    Li HQ; Shi L; Li QS; Liu PG; Luo Y; Zhao J; Zhu HL
    Bioorg Med Chem; 2009 Sep; 17(17):6264-9. PubMed ID: 19664929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and antibacterial activities of vanillic acylhydrazone derivatives as potential β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
    Wang XL; Zhang YB; Tang JF; Yang YS; Chen RQ; Zhang F; Zhu HL
    Eur J Med Chem; 2012 Nov; 57():373-82. PubMed ID: 23124163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based design, synthesis, and study of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III as potential antimicrobial agents.
    Nie Z; Perretta C; Lu J; Su Y; Margosiak S; Gajiwala KS; Cortez J; Nikulin V; Yager KM; Appelt K; Chu S
    J Med Chem; 2005 Mar; 48(5):1596-609. PubMed ID: 15743201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and modification of sulfur-containing heterocyclic pyrazoline derivatives as potential novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
    Yang YS; Zhang F; Gao C; Zhang YB; Wang XL; Tang JF; Sun J; Gong HB; Zhu HL
    Bioorg Med Chem Lett; 2012 Jul; 22(14):4619-24. PubMed ID: 22721711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structures of bacterial FabH suggest a molecular basis for the substrate specificity of the enzyme.
    Gajiwala KS; Margosiak S; Lu J; Cortez J; Su Y; Nie Z; Appelt K
    FEBS Lett; 2009 Sep; 583(17):2939-46. PubMed ID: 19665020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural evidence for the covalent modification of FabH by 4,5-dichloro-1,2-dithiol-3-one (HR45).
    Ekström AG; Kelly V; Marles-Wright J; Cockroft SL; Campopiano DJ
    Org Biomol Chem; 2017 Aug; 15(30):6310-6313. PubMed ID: 28715001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationship-based screening of antibiotics against Gram-negative Acinetobacter baumannii.
    Lee JY; Jeong MC; Jeon D; Lee Y; Lee WC; Kim Y
    Bioorg Med Chem; 2017 Jan; 25(1):372-380. PubMed ID: 27840136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, molecular modeling and biological evaluation of PSB as targeted antibiotics.
    Cheng K; Zheng QZ; Hou J; Zhou Y; Liu CH; Zhao J; Zhu HL
    Bioorg Med Chem; 2010 Apr; 18(7):2447-55. PubMed ID: 20304657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiolactomycin-Based Inhibitors of Bacterial β-Ketoacyl-ACP Synthases with in Vivo Activity.
    Bommineni GR; Kapilashrami K; Cummings JE; Lu Y; Knudson SE; Gu C; Walker SG; Slayden RA; Tonge PJ
    J Med Chem; 2016 Jun; 59(11):5377-90. PubMed ID: 27187871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification, characterization, and identification of novel inhibitors of the beta-ketoacyl-acyl carrier protein synthase III (FabH) from Staphylococcus aureus.
    He X; Reynolds KA
    Antimicrob Agents Chemother; 2002 May; 46(5):1310-8. PubMed ID: 11959561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free energy calculations on the binding of novel thiolactomycin derivatives to E. coli fatty acid synthase I.
    Steinbrecher T; Case DA; Labahn A
    Bioorg Med Chem; 2012 Jun; 20(11):3446-53. PubMed ID: 22560835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of 4-Pyridone derivatives as specific inhibitors of enoyl-acyl carrier protein reductase (FabI) with antibacterial activity against Staphylococcus aureus.
    Takahata S; Iida M; Yoshida T; Kumura K; Kitagawa H; Hoshiko S
    J Antibiot (Tokyo); 2007 Feb; 60(2):123-8. PubMed ID: 17420562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.